Lacktman Quoted on Personalized Medicine in Florida
28 January 2011
Tampa Bay Business Journal
Foley Senior Counsel Nathaniel Lacktman was quoted in an article that appeared in the Tampa Bay Business Journal on January 28, 2011 titled “Clinical trials seen as driving economic sector; M2Gen’s presence helping.” Lacktman discusses the efforts of M2Gen, the for-profit subsidiary of Moffitt Cancer Center, to help position the Tampa Bay region as a national leader in drug development. He states that M2Gen’s work should draw drug developers, physicians and other service providers to the area.
People
Related News
13 January 2025
In the News
Matthew Krueger Assesses Government Health Care Enforcement Focuses for 2025
Foley & Lardner LLP partner Matthew Krueger assessed several key government health care enforcement targets for the year ahead in the Report on Medicare Compliance article, "Outlook 2025: Look for MA Cases Based on Claim Denials; Incoming DOJ May Tweak Guidance," published by the Health Care Compliance Association.
13 January 2025
In the News
Aaron Maguregui on HHS Cybersecurity Revamp – 'Going to be added costs across the board'
Foley & Lardner LLP partner Aaron Maguregui assessed the U.S. Department of Health and Human Services' (HHS) proposed overhaul of its cybersecurity rules in the Bloomberg Law article, "Health Supply-Chain Hacks Targeted by HHS Cybersecurity Rule."
13 January 2025
In the News
Judith Waltz Describes Potential Health Policy Changes Under New Administration
Foley & Lardner LLP partner Judith Waltz commented on potential health policy changes under the incoming presidential administration in the Report on Medicare Compliance article, "Outlook 2025: Disruption Is Expected, Along With More OIG Guidance, Payment Changes," published by the Health Care Compliance Association.